Vedanta Biosciences logo

Vedanta Biosciences

ID: 5311216

A biotechnology company that develops medicines based on live bacterial consortia that can colonize the human intestine.

13

Funding Rounds

$386.6m

Money raised

Overview

A biotechnology company that develops medicines based on live bacterial consortia that can colonize the human intestine.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Vedanta Biosciences has raised a total of $305.8m in funding over 13 rounds.

Key Insights:

  • Vedanta Biosciences Series D round, July 2021: $68m
  • Vedanta Biosciences Venture round, January 12, 2021: $25m
  • Vedanta Biosciences Grant (money), September 30, 2020: $76.9m
  • Vedanta Biosciences funding round, September 2019: $16.6m
  • Vedanta Biosciences Series C round, May 13, 2019: $18.5m
  • Vedanta Biosciences Series C round, December 24, 2018: $45.4m
  • Vedanta Biosciences Grant (money), November 3, 2017: $5.4m
  • Vedanta Biosciences Private equity, June 6, 2016: $50m
  • Vedanta Biosciences Grant (money), December 2019: $5.8m
  • VEDANTA BIOSCIENCES, INC. funding round, August 2021: $75m